The stricken Cambridge UK technology company Pursuit Dynamics has battled hard to eliminate most of the liabilities associated with its PDX business and may wipe them all out by the end of June.

Medical technology pioneer AstraZeneca has chosen the Cambridge Biomedical Campus at the Addenbrooke’s Hospital site in Cambridge UK for its new global headquarters.

Cambridge UK medical technology business Phytopharm reported an unaudited post-tax loss of £2.65 million for the six months to the end of March but it was the cash burn that evidenced the reasons for the company’s urgent restructuring.

A novel inhaler for cystic fibrosis suffers using saltwater treatment has been developed in a Cambridge UK-North Carolina technology alliance.

Cambridge medical technology business Phytopharm plc has suspended trading on the UK’s main market pending a potentially transformational acquisition which is at the heart of an urgent restructuring.

Inhaled therapies pioneer Vectura, which has operations in the Cambridge UK technology cluster, plans to use some of its £70 million war chest for fresh commercial ventures to accelerate growth.

The Queen is to officially open the new building for the Medical Research Council  (MRC) Laboratory of Molecular Biology at the heart of the Cambridge UK technology cluster on Thursday, May 23.

Babraham Institute in Cambridge has formed a new venture to commercialise its vast IP portfolio and expand collaboration opportunities with global researchers and companies – a move that boosts the UK’s capabilities for medical technology innovation.

A Cambridge-Belgium technology collaboration has created a device which helps people whose speech has been impaired by crippling conditions to find their voice.

The University of Cambridge and University College London (UCL) will share in a £50 million bonus haul from the UK government designed to unearth new technology and encourage entrepreneurship to advance medical innovation.

Medical technology business Vectura, which has research operations in Cambridge UK, has launched a major push in Asia by establishing a joint venture with Chinese and Hong Kong partners.

The crucial first hours of an embryo can now be captured for the first time by new imaging technology being pioneered at the Bourn Hall Clinic in Cambridge UK – boosting the success chances of IVF, according to experts.

Cambridge medical technology business, GW Pharmaceuticals, has earned a key European approval for its cannabis-based prescription medicine Sativex® in Italy – and a €250k windfall in the process.

Cambridge medical technology business, GW Pharmaceuticals, has earned a key European approval for its cannabis-based prescription medicine Sativex® in Italy – and a €250k windfall in the process.

A Cambridge regenerative medicine business whose technology uses a patient’s own tissue to rebuild breasts after cancer surgery has boosted its capabilities with a UK acquisition.

Pioneering software is being developed in Cambridge UK to deliver personalised radiotherapy treatment to individual cancer patients.

GW Pharmaceuticals, the Cambridge UK biopharma business whose products are developed from cannabis, has made a bullish bow on the US technology market NASDAQ – raising $31.2 million in an over-subscribed IPO.